These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16168062

  • 21. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J, Larsson P, Rott Z, Böcskei C, Poczi M, Juhász G.
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [Abstract] [Full Text] [Related]

  • 22. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH, Otis J, Kline PA, Gontovnick LS, Hargreave FE, O'Byrne PM.
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [Abstract] [Full Text] [Related]

  • 23. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 24. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma.
    Irwin RS, French CT, Smyrnios NA, Curley FJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1981-7. PubMed ID: 9308510
    [Abstract] [Full Text] [Related]

  • 25. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
    Bijl-Hofland ID, Cloosterman SG, Folgering HT, van den Elshout FJ, van Weel C, van Schayck CP.
    Am J Respir Crit Care Med; 2001 Sep 01; 164(5):764-9. PubMed ID: 11549530
    [Abstract] [Full Text] [Related]

  • 26. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
    Lipworth BJ, Dempsey OJ, Aziz I.
    Chest; 2000 Aug 01; 118(2):321-8. PubMed ID: 10936119
    [Abstract] [Full Text] [Related]

  • 27. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH, Sussman HS, Shaw MJ, Barnes PJ, Chung KF.
    Am J Respir Crit Care Med; 1995 Oct 01; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of inhaled formoterol in reversing bronchoconstriction.
    Rubin AS, Perin C, Pelegrin L, Fernandes JC, da Silva LC.
    J Bras Pneumol; 2006 Oct 01; 32(3):202-6. PubMed ID: 17273608
    [Abstract] [Full Text] [Related]

  • 29. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
    Parameswaran KN, Inman MD, Ekholm BP, Morris MM, Summers E, O'Byrne PM, Hargreave FE.
    Am J Respir Crit Care Med; 1999 Jul 01; 160(1):354-7. PubMed ID: 10390425
    [Abstract] [Full Text] [Related]

  • 30. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ, Aziz I.
    Chest; 2000 Jan 01; 117(1):156-62. PubMed ID: 10631214
    [Abstract] [Full Text] [Related]

  • 31. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A, Brashier B, Maganji M, Raghupathy A, Mahadik P, Gokhale P, Gogtay J, Salvi S.
    Respir Med; 2007 Apr 01; 101(4):845-9. PubMed ID: 17276051
    [Abstract] [Full Text] [Related]

  • 32. Formoterol induces tolerance to the bronchodilating effect of Salbutamol following methacholine-provocation test in asthmatic children.
    Adler A, Uziel Y, Mei-Zahav M, Horowitz I.
    Pulm Pharmacol Ther; 2006 Apr 01; 19(4):281-5. PubMed ID: 16169761
    [Abstract] [Full Text] [Related]

  • 33. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL, Spezia E, Piovesan P, Chiocca E, Maiocchi G.
    Am J Respir Crit Care Med; 1994 Apr 01; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [Abstract] [Full Text] [Related]

  • 34. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
    Lebecque P, Vliers S, De Saint-Moulin T, Godding V.
    Rev Mal Respir; 1994 Apr 01; 11(1):47-50. PubMed ID: 7907426
    [Abstract] [Full Text] [Related]

  • 35. Bronchodilator tolerance: the impact of increasing bronchoconstriction.
    Wraight JM, Hancox RJ, Herbison GP, Cowan JO, Flannery EM, Taylor DR.
    Eur Respir J; 2003 May 01; 21(5):810-5. PubMed ID: 12765426
    [Abstract] [Full Text] [Related]

  • 36. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction.
    van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R.
    Respir Med; 2004 Sep 01; 98(9):816-20. PubMed ID: 15338791
    [Abstract] [Full Text] [Related]

  • 37. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.
    Respir Med; 2000 Aug 01; 94(8):767-71. PubMed ID: 10955752
    [Abstract] [Full Text] [Related]

  • 38. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
    Steffensen IE, Faurschou P.
    Ugeskr Laeger; 1996 Dec 02; 158(49):7092-6. PubMed ID: 8999618
    [Abstract] [Full Text] [Related]

  • 39. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
    Wong AG, O'Byrne PM, Lindbladh C, Inman MD, Stâhl E, Hargreave FE.
    Can Respir J; 1998 Dec 02; 5(2):119-23. PubMed ID: 9707454
    [Abstract] [Full Text] [Related]

  • 40. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
    FitzGerald JM, Chapman KR, Della Cioppa G, Stubbing D, Fairbarn MS, Till MD, Brambilla R.
    J Allergy Clin Immunol; 1999 Mar 02; 103(3 Pt 1):427-35. PubMed ID: 10069876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.